David G. Lowe has been a research scientist managing and leading drug discovery efforts; a venture capitalist investing in emerging and mid stage life science companies; and most recently a biotechnology entrepreneur. In 2012 David became co-founder and CEO of Aeglea BioTherapeutics, an Austin, TX-based startup developing cancer drugs targeting tumor metabolism.
Where should any financial technology startup live? We’re here to urge you to look no further, and seriously consider Boston. Boston is and will remain the perfect home for FinTech startups today and for years to come. Read on to learn why we’re so confident.